Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review
The management and treatment of major depressive disorder are major public health challenges, the lifetime prevalence of this illness being 4.4% –20% in the general population. Major depressive disorder and treatment resistant depression appear to be, in part, related to a dysfunction of the immune response. Among the treatments for depression ECT occupies an important place. The underlying cerebral mechanisms of ECT remain unclear.
Source: BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation - Category: Neurology Authors: Antoine Yrondi, Marie Sporer, Patrice P éran, Laurent Schmitt, Christophe Arbus, Anne Sauvaget Source Type: research
More News: Brain | Depression | Electroconvulsive Therapy | International Medicine & Public Health | Neurology